2023-06-05 08:14:50 ET
- Bellerophon Therapeutic ( BLPH ) -71% announces top-line data from phase 3 REBUILD clinical trial of INOpulse® for treatment of fibrotic interstitial lung disease.
- Mallinckrodt MNK -18% to consider filing for bankruptcy again - WSJ.
- EPAM Systems EPAM -14% lowers Q2 and FY outlook due to slowdown and continued uncertainty in demand.
- SunCar Technology Group ( SDA ) -11% .
- CNS Pharmaceuticals ( CNSP ) -5% .
- Genprex ( GNPX ) -8% .
- BitNile Metaverse ( BNMV ) -6% .
- Connect Biopharma Holdings ( CNTB ) -6% .
For further details see:
GNPX, CNSP and SDA among pre-market losers